18 Jul 2018 13:52
18 July 2018
Circassia Pharmaceuticals plc
Issue of Equity and Total Voting Rights
Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) announces that, further to the announcement made on 16th July 2018, 23,725,800 Ordinary Shares have been admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities (together, "Admission").
In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia confirms that the Company's issued share capital consists of 357,192,062 Ordinary Shares, each with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Circassia Pharmaceuticals plc
Julien Cotta, Company Secretary +44 (0) 1865 405560